Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 2/2004

01.02.2004 | Clinical Investigation

Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia

verfasst von: Ariko Kojima, Kyoko Ohno-Matsui, Satoshi Teramukai, Takeshi Yoshida, Yoko Ishihara, Kanako Kobayashi, Noriaki Shimada, Kenjiro Yasuzumi, Soh Futagami, Takashi Tokoro, Manabu Mochizuki

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the influencing factors on the development of chorioretinal atrophy, which is the main cause of long-term visual decrease in myopic choroidal neovascularization (CNV), in a large series of highly myopic patients.

Methods

Sixty-five patients (81 eyes) with myopic CNV were studied retrospectively. The influence of the patient’s age, refractive error, axial length, visual acuity at onset of CNV, size of CNV, and grade of myopic retinopathy on the extent of chorioretinal atrophy more than 3 years after CNV onset was investigated by means of multiple linear regression analysis.

Results

Seventy-seven of 81 eyes (95.1%) developed chorioretinal atrophy around myopic CNV during the follow-up period. Multiple linear regression revealed that age was the most influencing factor for the development of chorioretinal atrophy in all the subjects. When we divided the subjects into two groups according to their age, however, CNV size was the only factor to influence the development of chorioretinal atrophy in the patients younger than 40 years, whereas age was still the only influencing factor in those older than 40 years.

Conclusions

The factors influencing the development of chorioretinal atrophy differ according to patient age. Local factors, such as CNV size, determine the tendency to develop chorioretinal atrophy in young patients. Systemic factors, such as patient age, play a greater part in older subjects.
Literatur
1.
Zurück zum Zitat Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581CrossRefPubMed Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573–1581CrossRefPubMed
2.
Zurück zum Zitat Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241–1244CrossRefPubMed Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241–1244CrossRefPubMed
3.
Zurück zum Zitat Curtin BJ (1985) Basic science and clinical management. In: Curtin BJ (ed) The myopias. Harper & Row, Philadelphia, pp 237–245 Curtin BJ (1985) Basic science and clinical management. In: Curtin BJ (ed) The myopias. Harper & Row, Philadelphia, pp 237–245
4.
Zurück zum Zitat Delori FC, Goger DG, Dorey CK (2001) Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 42:1855–1866PubMed Delori FC, Goger DG, Dorey CK (2001) Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci 42:1855–1866PubMed
5.
Zurück zum Zitat Docchio F (1989) Ocular fluorometry: principles, fluorophores, instrumentation, and clinical applications. Lasers Surg Med 9:515–532CrossRefPubMed Docchio F (1989) Ocular fluorometry: principles, fluorophores, instrumentation, and clinical applications. Lasers Surg Med 9:515–532CrossRefPubMed
6.
7.
Zurück zum Zitat Harman AM, Hoskins R, Beazley LD (1999) Experimental eye enlargement in mature animals changes the retinal pigment epithelium. Vis Neurosci 16:619–628CrossRefPubMed Harman AM, Hoskins R, Beazley LD (1999) Experimental eye enlargement in mature animals changes the retinal pigment epithelium. Vis Neurosci 16:619–628CrossRefPubMed
8.
Zurück zum Zitat Hayasaka S, Uchida M, Setogawa T (1990) Subretinal hemorrhages with or without choroidal neovascularization in the maculas of patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol 228:277–280CrossRefPubMed Hayasaka S, Uchida M, Setogawa T (1990) Subretinal hemorrhages with or without choroidal neovascularization in the maculas of patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol 228:277–280CrossRefPubMed
9.
Zurück zum Zitat Hotchkiss ML, Fine SL (1981) Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91:177–183CrossRefPubMed Hotchkiss ML, Fine SL (1981) Pathologic myopia and choroidal neovascularization. Am J Ophthalmol 91:177–183CrossRefPubMed
10.
Zurück zum Zitat Kitaya N, Ishiko S, Abiko T, Mori F, Kagokawa H, Kojima M, Saito K, Yoshida A (2000) Changes in blood-retinal barrier permeability in form deprivation myopia in tree shrews. Vision Res 40:2369–2377CrossRefPubMed Kitaya N, Ishiko S, Abiko T, Mori F, Kagokawa H, Kojima M, Saito K, Yoshida A (2000) Changes in blood-retinal barrier permeability in form deprivation myopia in tree shrews. Vision Res 40:2369–2377CrossRefPubMed
11.
Zurück zum Zitat Montero JA, Ruiz-Moreno JM (2003) Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 87:173–176CrossRefPubMedPubMedCentral Montero JA, Ruiz-Moreno JM (2003) Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 87:173–176CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Pruett RC (1994) Pathologic myopia. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology. Saunders, Philadelphia, pp 878–882 Pruett RC (1994) Pathologic myopia. In: Albert DM, Jakobiec FA (eds) Principles and practice of ophthalmology. Saunders, Philadelphia, pp 878–882
13.
Zurück zum Zitat Sperduto RD, Seigel D, Roberts J, Rowland M (1983) Prevalence of myopia in the United States. Arch Ophthalmol 101:405–407CrossRefPubMed Sperduto RD, Seigel D, Roberts J, Rowland M (1983) Prevalence of myopia in the United States. Arch Ophthalmol 101:405–407CrossRefPubMed
14.
Zurück zum Zitat Tabandeh H, Flynn HW Jr., Scott IU, Lewis ML, Rosenfeld PJ, Rodriguesz F, Rodriguesz A, Singerman LJ, Schiffman J (1999) Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 106:2063–2067CrossRefPubMed Tabandeh H, Flynn HW Jr., Scott IU, Lewis ML, Rosenfeld PJ, Rodriguesz F, Rodriguesz A, Singerman LJ, Schiffman J (1999) Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology 106:2063–2067CrossRefPubMed
15.
Zurück zum Zitat Tokoro T (1988) On the definition of pathologic myopia in group studies. Acta Ophthalmol 66:107–108CrossRef Tokoro T (1988) On the definition of pathologic myopia in group studies. Acta Ophthalmol 66:107–108CrossRef
16.
Zurück zum Zitat Tokoro T (1998) Criteria for diagnosis of pathologic myopia. In: Tokoro T (ed) Atlas of posterior fundus changes in pathologic myopia. Springer, New York Berlin Heidelberg, pp 1–2 Tokoro T (1998) Criteria for diagnosis of pathologic myopia. In: Tokoro T (ed) Atlas of posterior fundus changes in pathologic myopia. Springer, New York Berlin Heidelberg, pp 1–2
17.
Zurück zum Zitat Tokoro T (1998) Myopic choroidal neovascularization (Fuchs’ spot). In: Tokoro T (ed) Atlas of posterior fundus changes in pathologic myopia. Springer, New York Berlin Heidelberg, pp 161–201 Tokoro T (1998) Myopic choroidal neovascularization (Fuchs’ spot). In: Tokoro T (ed) Atlas of posterior fundus changes in pathologic myopia. Springer, New York Berlin Heidelberg, pp 161–201
18.
Zurück zum Zitat Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial. VIP report no. 3. Ophthalmology 110:667–673CrossRef Verteporfin in Photodynamic Therapy (VIP) Study Group (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial. VIP report no. 3. Ophthalmology 110:667–673CrossRef
19.
Zurück zum Zitat Yoshida A, Ishiko S, Kojima M (1996) Inward and outward permeability of the blood-retinal barrier in experimental myopia. Graefes Arch Clin Exp Ophthalmol 234: S239–242CrossRefPubMed Yoshida A, Ishiko S, Kojima M (1996) Inward and outward permeability of the blood-retinal barrier in experimental myopia. Graefes Arch Clin Exp Ophthalmol 234: S239–242CrossRefPubMed
20.
Zurück zum Zitat Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia. A comparison between age groups. Ophthalmology 109:712–719CrossRefPubMed Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia. A comparison between age groups. Ophthalmology 109:712–719CrossRefPubMed
21.
Zurück zum Zitat Yoshida T, Ohno-Matsui K, Yasuzumi K (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1257–1305 Yoshida T, Ohno-Matsui K, Yasuzumi K (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1257–1305
Metadaten
Titel
Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia
verfasst von
Ariko Kojima
Kyoko Ohno-Matsui
Satoshi Teramukai
Takeshi Yoshida
Yoko Ishihara
Kanako Kobayashi
Noriaki Shimada
Kenjiro Yasuzumi
Soh Futagami
Takashi Tokoro
Manabu Mochizuki
Publikationsdatum
01.02.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 2/2004
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-003-0803-9

Weitere Artikel der Ausgabe 2/2004

Graefe's Archive for Clinical and Experimental Ophthalmology 2/2004 Zur Ausgabe

Announcements

February 2004

Neu im Fachgebiet Augenheilkunde

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.